| R2032508 |
PRT062607 Hydrochloride(P505-15 Hydrochloride;BIIB057 Hydrochloride) |
PRT062607 Hydrochloride (P505-15 Hydrochloride) is a highly specific and potent
|
| R2032509 |
PSI-6206 |
PSI-6206 (RO 2433) is the deaminated derivative of PSI-6130, which is a potent a
|
| R2032510 |
Purmorphamine |
Purmorphamine (Shh Signaling Antagonist VI) is a smoothened receptor agonist wit
|
| R2032511 |
PYR41 |
PYR-41 is a selective and cell permeable inhibitor of ubiquitin-activating enzym
|
| R2032512 |
RAF265(CHIR-265) |
RAF265 is a potent RAF/VEGFR2 inhibitor.
|
| R2032513 |
RGFP966 |
RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits
|
| R2032514 |
Rigosertib(ON-01910) |
Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9
|
| R2032515 |
RKI-1447 |
RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2 with IC50 value
|
| R2032516 |
RN486 |
RN486 is a selective Btk inhibitor with an IC50 Value of 4.0 nM.IC50 Value: 4.0
|
| R2032517 |
RO5126766(CH5126766) |
Ro 5126766 is a first-in-class dual MEK/RAF inhibitor that allosterically inhibi
|
| R2032518 |
SAL003 |
Sal003 is a potent, specific and cell-permeable inhibitor of the eukaryotic tran
|
| R2032519 |
SB1317 Hydrochloride(TG02) |
SB1317 is a potent inhibitor of CDK2, JAK2, and FLT3 for the treatment of cancer
|
| R2032520 |
SB271046 |
SB271046 Hcl is a potent, selective and orally active 5-HT6 receptor antagonist
|
| R2032521 |
SB505124 |
SB-505124 is a selective inhibitor of TGF-β Receptor type I receptor (ALK4, ALK5
|
| R2032522 |
SB743921 |
SB-743921 is a potent inhibitor of the mitotic kinesin KSP (Eg5), with a Ki of 0
|
| R2032523 |
SC-514 |
SC-514 is a selective IKK-2 inhibitor (IC50=11.2±4.7 μM), which does not inhibit
|
| R2032524 |
SGC0946 |
SGC0946 is a highly potent and selective DOT1L methyltransferase inhibitor with
|
| R2032525 |
SGX-523 |
SGX-523 is a selective Met inhibitor with IC50 of 4 nM, no activity to BRAFV599E
|
| R2032526 |
Skepinone-L;CBS3830 |
Skepinone-L (CBS3830) is a selective p38 mitogen-activated protein kinase inhibi
|
| R2032527 |
SKLB1002 |
SKLB1002 is a potent and ATP-competitive VEGFR2 inhibitor with IC50 of 32 nM.
|
| R2032528 |
SKLB610 |
SKLB1002 is a potent and ATP-competitive VEGFR2 inhibitor with IC50 of 32 nM.
|
| R2032529 |
SNS-032(BMS-387032) |
SNS-032 (BMS-387032) is a selective inhibitor of CDK2, CDK7, and CDK9 with IC50s
|
| R2032530 |
SNS-314 Mesylate |
SNS-314 is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, a
|
| R2032531 |
SSR128129E |
SSR128129E is an orally available and allosteric FGFR inhibitor with an IC50 of
|
| R2032532 |
SteMRegenin 1 |
StemRegenin 1 is a potent aryl hydrocarbon receptor (AhR) antagonist with IC50 o
|